Resonance Health raises $4.22M to fund obesity-trial push
What's the deal? Resonance HealthDealroom has a profile for this one. Try Dealroom → (ASX: RHT), an Australian healthcare technology company serving clinicians and pharmaceutical firms, has completed an oversubscribed US$3.88M share placement. It drew firm commitments from institutional, professional, and sophisticated investors, with Bell Potter Securities managing the offer.
The details: The company issued roughly 83.3 million new shares at 7.2 cents each — a 6.4% discount to the five-day volume-weighted average price. Pro forma cash rises from US$3.11M to US$6.73M, with net cash climbing from US$1.49M to US$5.11M, based on adjusted June 30, 2026 figures.
What's the endgame? The funds fully finance three growth programmes over 24 months: US$776.5K for MRI endpoint acceleration in obesity imaging, US$970.6K to expand the TrialsWestDealroom has a profile for this one. Try Dealroom → investigator network, and US$970.6K for a non-invasive liver fibrosis device covering model refinement and regulatory filings. A further US$905.9K is set aside for working capital and potential bolt-on acquisitions.
Why now? Resonance is targeting demand from GLP-1, metabolic, and obesity clinical trials, which lifts need for its imaging endpoints and trial sites. The raise follows a strong FY26: revenue rose 42% to US$10.2M, the company returned to profit, and it posted positive operating cash flow every quarter.
What they're saying: Chief executive officer and managing director Andrew Harrison called the shareholder support "a clear endorsement of our strategy," adding that it strengthens "an already profitable, cash-generative business."
The signal: An oversubscribed placement into a profitable small-cap points to investor appetite for picks-and-shovels plays on the obesity-drug boom. The open question is whether the capital accelerates commercial returns fast enough to justify the step-up — details the company has yet to establish.
Read more: sharecafe.com.au
Image credit: National Institutes of Health (NIH)
